Lovastatin is an HMG-CoA reductase inhibitor belonging to the statin class, widely used to treat hyperlipidemia and prevent cardiovascular disease by effectively lowering cholesterol levels. To ensure… Read more

![Chemical structure of (4R,6R)-6-[2-[(1S,2S,4aR,6R,8aS)-2,6-Dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]ethyl]-4-hydroxyoxan-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F86827-77-2-4R6R-6-2-1S2S4aR6R8aS-26-Dimethyl-124a56788a-octahydronaphthalen-1-ylethyl-4-hydroxyoxan-2-one.png&w=3840&q=75)


![Chemical structure of 6(R)-{2-[8(S)-2-Methyl-d3-butyryloxy-2(S),6(R)-dimethyl-1,2,6,7,8,8d(R)-hexahydro-1(S)-naphthyl]ethyl}-4(R)-tert-butyldimethylsilyloxy-3,4,5,6-tetrahydro-2H-pyran-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1217723-49-3-6R-2-8S-2-Methyl-d3-butyryloxy-2S6R-dimethyl-126788dR-hexahydro-1S-naphthylethyl-4R-tert-butyldimethylsilyloxy-3456-tetrahydro-2H-pyran-2.png&w=3840&q=75)





















![Chemical structure of Lovastatin-d9 Epimer Mixture [(±)-2-methylbutyrate-d9]](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FLovastatin-d9-Epimer-Mixture-2-methylbutyrate-d9.png&w=3840&q=75)

Lovastatin is an HMG-CoA reductase inhibitor belonging to the statin class, widely used to treat hyperlipidemia and prevent cardiovascular disease by effectively lowering cholesterol levels. To ensure pharmaceutical safety and efficacy, laboratories rely on high-quality reference standards of lovastatin and its associated derivatives. This category provides a comprehensive selection of pharmacopeial and non-pharmacopeial impurities, including various dehydro and dihydro analogues, which are essential for rigorous impurity profiling during drug development. Furthermore, stable isotope labelled compounds such as lovastatin-d3 and lovastatin-d9 serve as vital internal standards for mass spectrometry-based analysis. These materials facilitate precise method validation, accurate quantification, and consistent quality control, helping researchers meet the stringent regulatory standards required for maintaining the integrity of pharmaceutical testing protocols for the parent drug and its related substances.